When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don ...

A new strategy developed by Professor Nathan Gianneschi grabs cancer-driving proteins and directs them to the cell’s disposal ...

Polyamines—natural molecules found in every living cell—have become stars in the longevity world for their ability to boost cellular cleanup and support healthy aging. But there’s a dark twist: high ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

Memorial Sloan Kettering Cancer Center investigators and collaborators have tested rezatapopt, an oral p53 reactivator ...

Intrinsically disordered proteins lack a fixed structure, which is why they have been considered "undruggable" targets for ...

A new blood test that combines four protein biomarkers can detect early-stage pancreatic cancer with nearly 88% accuracy, ...

A new study is shining a light on a potential way to make treatments work better for one of the deadliest forms of cancer. Researchers at Ohio University have identified a protein that could be a ...

Soheil Meshinchi, MD, PhD, a world leader in developing novel approaches to treating acute myeloid leukemia (AML), has been ...

Researchers say study results provide a clear rationale for developing therapies that target LCN2 in lung cancer patients.

The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or older should receive a protein subunit Respiratory Syncytial Virus (RSV) ...